1. P168 Predicting outcome in acute severe ulcerative colitis: Comparison of the Oxford, Edinburgh, Lindgren and endoscopic Mayo scores. (16th January 2018) Authors: Bernardo, S; Fernandes, S; Gonçalves, A R; Baldaia, C; Valente, A; Moura Santos, P; Correia, L; Velosa, J Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S182 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P304 Intensified versus conventional infliximab induction in acute severe steroid-refractory Ulcerative Colitis. (21st January 2022) Authors: Pedro, J; Coelho Rodrigues, I; Botto, I; Fernandes, S; Bernardo, S; Gonçalves, A R; Moura Santos, P; Valente, A; Correia, L; Tato Marinho, R Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i332 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P368 Proactive Therapeutic Drug Monitoring is more effective than Conventional Management in Inducing Fecal Calprotectin remission in Inflammatory Bowel Disease. (27th May 2021) Authors: Pedro, J; Rodrigues, I; Fernandes, S; Gonçalves, A R; Bernardo, S; Baldaia, C; Valente, A; Moura Santos, P; Correia, L; Tato Marinho, R Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S386 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P373 Psoriasis and psoriasiform skin lesions in patients with Inflammatory Bowel Disease treated with infliximab: a pharmacokinetic analysis. (27th May 2021) Authors: Rodrigues, I; Damião, F; Serrazina, J; Fernandes, S; Bernardo, S; Gonçalves, A R; Moura Santos, P; Baldaia, C; Valente, A; Correia, L; Tato Marinho, R Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S390 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P386 Association of Infliximab trough levels and perianal disease activity in Crohn's disease. (25th January 2019) Authors: Simões, C; Fernandes, S; Bernardo, S; Gonçalves, A R; Baldaia, C; Valente, A; Moura Santos, P; Correia, L; Tato Marinho, R Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S300 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P428 Early and Late Fecal Calprotectin Remission - Analysis of a proactive Therapeutic Drug Monitoring Treatment Protocol. (27th May 2021) Authors: Pedro, J; Rodrigues, I; Damião, F; Fernandes, S; Gonçalves, A R; Bernardo, S; Baldaia, C; Valente, A; Moura Santos, P; Correia, L; Tato Marinho, R Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S432 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P450 Association of Infliximab trough levels and transmural healing in Crohn's disease. (25th January 2019) Authors: Bernardo, S; Fernandes, S; Simões, C; Gonçalves, A R; Baldaia, C; Valente, A; Moura Santos, P; Correia, L; Marinho, R Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S336 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P510 Comparative effectiveness of Ustekinumab against other biologics in Inflammatory Bowel Disease: a propensity score analysis. (30th January 2023) Authors: Matos Coelho Bernardo, S; Fernandes, S; Serrazina, J; Rodrigues, I; Botto, I; Bronze, S; Gonçalves, A R; Valente, A; Santos, P M D; Tato Marinho, R; Correia, L Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i640 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P532 Proactive therapeutic drug monitoring improves clinical outcomes in patients with inadequate post-induction infliximab trough levels. (21st January 2022) Authors: Botto, I; Coelho Rodrigues, I; Serrazina, J; Fernandes, S; Bernardo, S; Gonçalves, A R; Moura Santos, P; Valente, A; Correia, L; Tato Marinho, R Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i484 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P581 Transmural remission improves clinical outcomes up to 5 years in patients with Crohn's Disease. (21st January 2022) Authors: Pedro, J; Botto, I; Fernandes, S; Lemos, J; Neves, J; Campelo, P; Carvalho, D; Bernardo, S; Gonçalves, A R; Valente, A; Moura Santos, P; Rosa, I; Tavares de Sousa, H; Ramos, J; Venâncio, J; Leitão, J; Claro, I; Correia, L; Tato Marinho, R Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i521 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗